{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T02:08:11Z","timestamp":1788055691147,"version":"build-2784847793"},"publisher-location":"New York, NY","reference-count":39,"publisher":"Springer US","isbn-type":[{"value":"9781071606346","type":"print"},{"value":"9781071606353","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0635-3_1","type":"book-chapter","created":{"date-parts":[[2020,5,25]],"date-time":"2020-05-25T11:02:38Z","timestamp":1590404558000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Praziquantel: An Enigmatic, Yet Effective, Drug"],"prefix":"10.1007","author":[{"given":"David J.","family":"Timson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,26]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"w13727","DOI":"10.4414\/smw.2012.13727","volume":"142","author":"J Utzinger","year":"2012","unstructured":"Utzinger J, Becker SL, Knopp S, Blum J, Neumayr AL, Keiser J, Hatz CF (2012) Neglected tropical diseases: diagnosis, clinical management, treatment and control. Swiss Med Wkly 142:w13727. \n                https:\/\/doi.org\/10.4414\/smw.2012.13727","journal-title":"Swiss Med Wkly"},{"issue":"9936","key":"1_CR2","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH (2014) Human schistosomiasis. Lancet 383(9936):2253\u20132264. \n                https:\/\/doi.org\/10.1016\/S0140-6736(13)61949-2","journal-title":"Lancet"},{"issue":"5","key":"1_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004546","volume":"10","author":"TA Houweling","year":"2016","unstructured":"Houweling TA, Karim-Kos HE, Kulik MC, Stolk WA, Haagsma JA, Lenk EJ, Richardus JH, de Vlas SJ (2016) Socioeconomic inequalities in neglected tropical diseases: a systematic review. PLoS Negl Trop Dis 10(5):e0004546. \n                https:\/\/doi.org\/10.1371\/journal.pntd.0004546","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"1_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","volume":"6","author":"P Steinmann","year":"2006","unstructured":"Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6(7):411\u2013425. \n                https:\/\/doi.org\/10.1016\/S1473-3099(06)70521-7","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"1_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1476-5381.1957.tb00114.x","volume":"12","author":"E Bueding","year":"1957","unstructured":"Bueding E, Mansour JM (1957) The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni. Br J Pharmacol Chemother 12(2):159\u2013165","journal-title":"Br J Pharmacol Chemother"},{"issue":"3","key":"1_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2174\/1389203717999160226180733","volume":"17","author":"DJ Timson","year":"2016","unstructured":"Timson DJ (2016) Metabolic enzymes of Helminth parasites: potential as drug targets. Curr Protein Pept Sci 17(3):280\u2013295","journal-title":"Curr Protein Pept Sci"},{"issue":"2","key":"1_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0166685196027028","volume":"81","author":"JG Su","year":"1996","unstructured":"Su JG, Mansour JM, Mansour TE (1996) Purification, kinetics and inhibition by antimonials of recombinant phosphofructokinase from Schistosoma mansoni. Mol Biochem Parasitol 81(2):171\u2013178. \n                https:\/\/doi.org\/10.1016\/0166685196027028","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"1_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0035-9203(87)90282-3","volume":"81","author":"R Foster","year":"1987","unstructured":"Foster R (1987) A review of clinical experience with oxamniquine. Trans R Soc Trop Med Hyg 81(1):55\u201359","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"Cd000053","DOI":"10.1002\/14651858.CD000053.pub3","volume":"8","author":"CV Kramer","year":"2014","unstructured":"Kramer CV, Zhang F, Sinclair D, Olliaro PL (2014) Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev 8:Cd000053. \n                https:\/\/doi.org\/10.1002\/14651858.CD000053.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1_CR10","first-page":"357","volume":"44","author":"H Feldmeier","year":"1987","unstructured":"Feldmeier H, Doehring E (1987) Clinical experience with metrifonate. Review with emphasis on its use in endemic areas. Acta Trop 44(3):357\u2013368","journal-title":"Acta Trop"},{"issue":"1","key":"1_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0163-7258(95)00026-7","volume":"68","author":"D Cioli","year":"1995","unstructured":"Cioli D, Pica-Mattoccia L, Archer S (1995) Antischistosomal drugs: past, present and future? Pharmacol Ther 68(1):35\u201385","journal-title":"Pharmacol Ther"},{"issue":"31","key":"1_CR12","doi-asserted-by":"publisher","first-page":"7936","DOI":"10.1002\/anie.201208390","volume":"52","author":"SA Thetiot-Laurent","year":"2013","unstructured":"Thetiot-Laurent SA, Boissier J, Robert A, Meunier B (2013) Schistosomiasis chemotherapy. Angew Chem Int Ed Engl 52(31):7936\u20137956. \n                https:\/\/doi.org\/10.1002\/anie.201208390","journal-title":"Angew Chem Int Ed Engl"},{"key":"1_CR13","volume-title":"19th WHO model list of essential medicines. 2015. World Health Organization","author":"Anonymous","year":"2015","unstructured":"Anonymous (2015) 19th WHO model list of essential medicines. 2015. World Health Organization. World Health Organization, Geneva"},{"issue":"6","key":"1_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/qco.0000000000000312","volume":"29","author":"DU Olveda","year":"2016","unstructured":"Olveda DU, McManus DP, Ross AG (2016) Mass drug administration and the global control of schistosomiasis: successes, limitations and clinical outcomes. Curr Opin Infect Dis 29(6):595\u2013608. \n                https:\/\/doi.org\/10.1097\/qco.0000000000000312","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"1_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","volume":"195","author":"D Cioli","year":"2014","unstructured":"Cioli D, Pica-Mattoccia L, Basso A, Guidi A (2014) Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol 195(1):23\u201329. S0166-6851(14)00075-9","journal-title":"Mol Biochem Parasitol"},{"issue":"1","key":"1_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000357","volume":"3","author":"T Meyer","year":"2009","unstructured":"Meyer T, Sekljic H, Fuchs S, Bothe H, Schollmeyer D, Miculka C (2009) Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatment. PLoS Negl Trop Dis 3(1):e357. \n                https:\/\/doi.org\/10.1371\/journal.pntd.0000357","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"1_CR17","first-page":"935","volume":"99","author":"YH Liu","year":"1986","unstructured":"Liu YH, Qian MX, Wang XG, Jia J, Wang QN, Jiang YF, Wang RQ, Yan SH, Chen BY, Li JS et al (1986) Comparative efficacy of praziquantel and its optic isomers in experimental therapy of schistosomiasis japonica in rabbits. Chin Med J 99(12):935\u2013940","journal-title":"Chin Med J"},{"issue":"3","key":"1_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/infdis\/159.3.589","volume":"159","author":"SH Xiao","year":"1989","unstructured":"Xiao SH, Catto BA (1989) Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoni. J Infect Dis 159(3):589\u2013592","journal-title":"J Infect Dis"},{"key":"1_CR19","volume-title":"WHO model prescribing information: drugs used in parasitic diseases","author":"Organization WHO","year":"1995","unstructured":"Organization WHO (1995) WHO model prescribing information: drugs used in parasitic diseases. World Health Organization, Geneva"},{"key":"1_CR20","volume-title":"Textbook of adult emergency medicine (E-book)","author":"S Manders","year":"2019","unstructured":"Manders S (2019) 9.11 tropical infectious diseases. In: Textbook of adult emergency medicine (E-book), 5th edn. Elsevier Health Sciences, Amsterdam","edition":"5"},{"issue":"9","key":"1_CR21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0169-4758(99)01510-0","volume":"15","author":"J Kusel","year":"1999","unstructured":"Kusel J, Hagan P (1999) Praziquantel--its use, cost and possible development of resistance. Parasitol Today 15(9):352\u2013354","journal-title":"Parasitol Today"},{"issue":"3","key":"1_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijpddr.2014.09.006","volume":"4","author":"IN Mwangi","year":"2014","unstructured":"Mwangi IN, Sanchez MC, Mkoji GM, Agola LE, Runo SM, Cupit PM, Cunningham C (2014) Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug. Int J Parasitol Drugs Drug Resist 4(3):296\u2013300. \n                https:\/\/doi.org\/10.1016\/j.ijpddr.2014.09.006","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"1_CR23","doi-asserted-by":"crossref","unstructured":"Thomas CM, Timson DJ (2020) The mechanism of action of praziquantel: can new drugs exploit similar mechanisms? Curr Med Chem 27(5):676\u2013696","DOI":"10.2174\/0929867325666180926145537"},{"issue":"1","key":"1_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1017\/S0022149X00005691","volume":"53","author":"GC Coles","year":"1979","unstructured":"Coles GC (1979) The effect of praziquantel on Schistosoma mansoni. J Helminthol 53(1):31\u201333","journal-title":"J Helminthol"},{"issue":"1","key":"1_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpara.2004.09.004","volume":"35","author":"RM Greenberg","year":"2005","unstructured":"Greenberg RM (2005) Are Ca2+ channels targets of praziquantel action? Int J Parasitol 35(1):1\u20139. \n                https:\/\/doi.org\/10.1016\/j.ijpara.2004.09.004","journal-title":"Int J Parasitol"},{"issue":"6","key":"1_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.parint.2012.12.001","volume":"62","author":"JD Chan","year":"2013","unstructured":"Chan JD, Zarowiecki M, Marchant JS (2013) Ca2+ channels and praziquantel: a view from the free world. Parasitol Int 62(6):619\u2013628. \n                https:\/\/doi.org\/10.1016\/j.parint.2012.12.001","journal-title":"Parasitol Int"},{"issue":"3","key":"1_CR27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1128\/AAC.01222-08","volume":"53","author":"M Gnanasekar","year":"2009","unstructured":"Gnanasekar M, Salunkhe AM, Mallia AK, He YX, Kalyanasundaram R (2009) Praziquantel affects the regulatory myosin light chain of Schistosoma mansoni. Antimicrob Agents Chemother 53(3):1054\u20131060. \n                https:\/\/doi.org\/10.1128\/AAC.01222-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 9","key":"1_CR28","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1017\/S0031182007002600","volume":"134","author":"F Angelucci","year":"2007","unstructured":"Angelucci F, Basso A, Bellelli A, Brunori M, Pica Mattoccia L, Valle C (2007) The anti-schistosomal drug praziquantel is an adenosine antagonist. Parasitology 134(Pt 9):1215\u20131221. \n                https:\/\/doi.org\/10.1017\/S0031182007002600","journal-title":"Parasitology"},{"issue":"1","key":"1_CR29","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41467-017-02084-0","volume":"8","author":"JD Chan","year":"2017","unstructured":"Chan JD, Cupit PM, Gunaratne GS, McCorvy JD, Yang Y, Stoltz K, Webb TR, Dosa PI, Roth BL, Abagyan R, Cunningham C, Marchant JS (2017) The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand. Nat Commun 8(1):1910. \n                https:\/\/doi.org\/10.1038\/s41467-017-02084-0","journal-title":"Nat Commun"},{"issue":"6","key":"1_CR30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1085\/jgp.201311153","volume":"143","author":"M Ben-Johny","year":"2014","unstructured":"Ben-Johny M, Yue DT (2014) Calmodulin regulation (calmodulation) of voltage-gated calcium channels. J Gen Physiol 143(6):679\u2013692. \n                https:\/\/doi.org\/10.1085\/jgp.201311153","journal-title":"J Gen Physiol"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceca.2018.05.006","volume":"74","author":"CM Thomas","year":"2018","unstructured":"Thomas CM, Timson DJ (2018) Calmodulins from Schistosoma mansoni: biochemical analysis and interaction with IQ-motifs from voltage-gated calcium channels. Cell Calcium 74:1\u201313","journal-title":"Cell Calcium"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"102161","DOI":"10.1016\/j.ceca.2020.102161","volume":"86","author":"CM Thomas","year":"2020","unstructured":"Thomas CM, Timson DJ (2020) The Schistosoma mansoni tegumental allergen protein, SmTAL1: binding to an IQ-motif from a voltage-gated ion channel and effects of praziquantel. Cell Calcium 86:102161","journal-title":"Cell Calcium"},{"issue":"4","key":"1_CR33","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1042\/BST20150270","volume":"44","author":"CM Thomas","year":"2016","unstructured":"Thomas CM, Timson DJ (2016) A mysterious family of calcium-binding proteins from parasitic worms. Biochem Soc Trans 44(4):1005\u20131010. \n                https:\/\/doi.org\/10.1042\/BST20150270","journal-title":"Biochem Soc Trans"},{"issue":"4","key":"1_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001593","volume":"6","author":"CM Fitzsimmons","year":"2012","unstructured":"Fitzsimmons CM, Jones FM, Stearn A, Chalmers IW, Hoffmann KF, Wawrzyniak J, Wilson S, Kabatereine NB, Dunne DW (2012) The Schistosoma mansoni tegumental-allergen-like (TAL) protein family: influence of developmental expression on human IgE responses. PLoS Negl Trop Dis 6(4):e1593. \n                https:\/\/doi.org\/10.1371\/journal.pntd.0001593","journal-title":"PLoS Negl Trop Dis"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.biochi.2014.10.015","volume":"108","author":"CM Thomas","year":"2015","unstructured":"Thomas CM, Fitzsimmons CM, Dunne DW, Timson DJ (2015) Comparative biochemical analysis of three members of the Schistosoma mansoni TAL family: differences in ion and drug binding properties. Biochimie 108:40\u201347. \n                https:\/\/doi.org\/10.1016\/j.biochi.2014.10.015","journal-title":"Biochimie"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.molbiopara.2018.02.002","volume":"221","author":"J Carson","year":"2018","unstructured":"Carson J, Thomas CM, McGinty A, Takata G, Timson DJ (2018) The tegumental allergen-like proteins of Schistosoma mansoni: a biochemical study of SmTAL4-TAL13. Mol Biochem Parasitol 221:14\u201322. \n                https:\/\/doi.org\/10.1016\/j.molbiopara.2018.02.002","journal-title":"Mol Biochem Parasitol"},{"issue":"18","key":"1_CR37","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.2174\/1568026618666181029143214","volume":"18","author":"CM Thomas","year":"2018","unstructured":"Thomas CM, Timson DJ (2018) The mechanism of action of Praziquantel: six hypotheses. Curr Top Med Chem 18(18):1575\u20131584. \n                https:\/\/doi.org\/10.2174\/1568026618666181029143214","journal-title":"Curr Top Med Chem"},{"key":"1_CR38","unstructured":"Park S-K, Gunaratne GS, Chulkov EG, Moehring F, McCusker P, Dosa PI, Chan JD, Stucky CL, Marchant JS (2019) The anthelmintic drug praziquantel activates a schistosome transient receptor potential channel. J Biol Chem 294(49):18873\u201318880"},{"key":"1_CR39","unstructured":"Park S-K, Marchant JS (2020) The journey to discovering a flatworm target of praziquantel: a long TRP. Trends Parasitol 36(2):182\u2013194"}],"container-title":["Methods in Molecular Biology","Schistosoma mansoni"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0635-3_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T12:03:44Z","timestamp":1601208224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0635-3_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071606346","9781071606353"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0635-3_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"26 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}